会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 91. 发明申请
    • DEMIBODIES: DIMERIZATION-ACTIVATED THERAPEUTIC AGENTS
    • 体育活动:二维激活治疗剂
    • US20090130106A1
    • 2009-05-21
    • US12095468
    • 2006-11-29
    • Richard Ian ChristophersonJacqueline Mary MatthewsJoel Peter MacKay
    • Richard Ian ChristophersonJacqueline Mary MatthewsJoel Peter MacKay
    • A61K39/395C07K16/00G01N33/53G01N33/574
    • C07K16/2887C07K14/43595C07K16/289C07K2317/622C07K2317/732C07K2319/00C07K2319/30
    • The present invention relates generally to a set of synthetic immunointeractive molecules referred to herein as “demibodies” which are useful in targeting particular cells in a subject. More particularly, the present invention provides a set of demibodies wherein at least two molecules from within the set, each specific for a different antigen on a target cell, are required to interact together at the cell surface in order to form an active complex which directs demibody-mediated cellular or complement mediated cytotoxicity and/or reporter function and/or therapeutic activity. The demibodies of the present invention are useful in the targeting of particular cells such as cancer cells including leukemic cells, pathogens including malarial, bacterial and viral agents, and stem cells including embryonic and adult stem cells and pathogen cells. The present invention provides, therefore, methods of treatment, diagnosis and undertaking research and compositions comprising demibodies useful for same.
    • 本发明一般涉及本文称为“抗体”的一组合成免疫相互作用分子,其可用于靶向受试者中的特定细胞。 更具体地说,本发明提供了一组抗体,其中需要来自组内的至少两个分子,每个特异于靶细胞上不同抗原的分子在细胞表面一起相互作用以形成活性复合物, 抗体介导的细胞或补体介导的细胞毒性和/或报告物功能和/或治疗活性。 本发明的抗体可用于靶向特定细胞,例如癌细胞,包括白血病细胞,包括疟疾,细菌和病毒剂的病原体,以及包括胚胎和成体干细胞和病原体细胞的干细胞。 因此,本发明提供治疗,诊断和进行研究的方法以及包含对其有用的抗体的组合物。